Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹11 Cr₹11 Cr₹-0.68 Cr₹3.63 Cr₹17 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?

The latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES is ₹11 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹11 Cr
Mar2023₹11 Cr
Mar2022₹-0.68 Cr
Mar2021₹3.63 Cr
Mar2020₹17 Cr

How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹11 Cr
2.54
Mar2023 ₹11 Cr
Positive
Mar2022 ₹-0.68 Cr
Negative
Mar2021 ₹3.63 Cr
-78.43
Mar2020 ₹17 Cr -

Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹425.4 Cr -11.1% 6% -22.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,003.0 Cr -1.6% -4.6% 14.7% Stock Analytics
DIVIS LABORATORIES ₹154,939.0 Cr -1.6% -1.3% 61.6% Stock Analytics
CIPLA ₹117,835.0 Cr 0.1% 1.2% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,787.0 Cr -2.1% -8.7% -2.3% Stock Analytics
ZYDUS LIFESCIENCES ₹90,722.1 Cr -6.5% -9.3% 8.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-11.1%

6%

-22.5%

SENSEX

-2.5%

-1.4%

6.1%


You may also like the below Video Courses